Phase 1 Study for Safety and Tolerability of EBI-005 Topically Administered to Eyes of Healthy Adult Subjects
Status:
Completed
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
This is a First-In-Human (FIH) study to assess the safety and tolerability of ocular
administration of EBI-005 in healthy volunteers. Additionally, the PK and immunogenicity of
EBI-005 will be assessed.